Skip to main content
Erschienen in: European Radiology 8/2006

01.08.2006 | Neuro

Short TE Quantitative Proton Magnetic Resonance Spectroscopy in Variant Creutzfeldt-Jakob Disease

verfasst von: R. J. Cordery, D. MacManus, A. Godbolt, M. N. Rossor, A. D. Waldman

Erschienen in: European Radiology | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegerative disorder. Clinical diagnosis is difficult in the early stages as the disease often presents with non-specific psychiatric and neurological symptoms. To investigate the diagnostic potential of quantitative short TE in vivo MRS, and the nature and anatomical distribution of biochemical abnormalities in vCJD, localised single-voxel spectra (TE/TR 30 ms/2,000 ms) were acquired from three brain regions: thalami, caudate nuclei and frontal white matter. Metabolite concentrations and ratios from three patients with definite or probable vCJD were compared with eight normal age-matched controls. Abnormal signal on T2-weighted MRI was apparent in the pulvinar region in all vCJD patients; this region also showed greatly increased myo-inositol [MI] (mean 2.5-fold, P=0.01) and decreased N-acetyl-aspartate (NAA; mean 2-fold, P=0.01). Two patients also showed increased [MI] (z=17, 11; one with decreased NAA, z=-12) in normal-appearing caudate nuclei. The magnitude of metabolite abnormalities in the thalami in moderately advanced vCJD suggests a potential role in earlier diagnosis. Short TE protocols allow the measurement of MI, which adds discriminant power to the MRS examination.
Literatur
1.
Zurück zum Zitat Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925CrossRefPubMed Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925CrossRefPubMed
2.
Zurück zum Zitat Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389:448–450CrossRefPubMed Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389:448–450CrossRefPubMed
3.
Zurück zum Zitat Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmissions to mice indicate that “new variant” CJD is caused by BSE. Nature 389:498–501CrossRefPubMed Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmissions to mice indicate that “new variant” CJD is caused by BSE. Nature 389:498–501CrossRefPubMed
4.
Zurück zum Zitat Will RG, Zeidler M, Stewart GE (2000) Diagnosis of New Variant Creutzfeldt-Jakob Disease. Ann Neurol 47:575–582CrossRefPubMed Will RG, Zeidler M, Stewart GE (2000) Diagnosis of New Variant Creutzfeldt-Jakob Disease. Ann Neurol 47:575–582CrossRefPubMed
7.
Zurück zum Zitat Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD, Collinge J (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like strains in transgenic mice expressing human prion protein. EMBO J 21(23):6358–6366CrossRefPubMed Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD, Collinge J (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like strains in transgenic mice expressing human prion protein. EMBO J 21(23):6358–6366CrossRefPubMed
8.
Zurück zum Zitat Zeidler M, Sellar RJ, Collie DA et al (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412–1418CrossRefPubMed Zeidler M, Sellar RJ, Collie DA et al (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412–1418CrossRefPubMed
9.
Zurück zum Zitat Bahn MM, Parchi P (1999) Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 56:577–583CrossRefPubMed Bahn MM, Parchi P (1999) Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 56:577–583CrossRefPubMed
10.
Zurück zum Zitat Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G (1999). Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 52:205–208CrossRefPubMed Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G (1999). Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 52:205–208CrossRefPubMed
11.
Zurück zum Zitat Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R (1997) Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet 349:847–848CrossRefPubMed Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R (1997) Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet 349:847–848CrossRefPubMed
12.
Zurück zum Zitat Waldman AD, Jarman P, Merry RTG (2003) Rapid echoplanar imaging in variant Creutzfeldt-Jakob disease: where speed is of the essence. Neuroradiology 45(8):528–531CrossRefPubMed Waldman AD, Jarman P, Merry RTG (2003) Rapid echoplanar imaging in variant Creutzfeldt-Jakob disease: where speed is of the essence. Neuroradiology 45(8):528–531CrossRefPubMed
13.
Zurück zum Zitat Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I (2001) Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 25(2):274–277CrossRefPubMed Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I (2001) Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 25(2):274–277CrossRefPubMed
14.
Zurück zum Zitat Bruhn H, Weber T, Thorwirth V, Frahm J (1991) In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 337:1610–1611CrossRefPubMed Bruhn H, Weber T, Thorwirth V, Frahm J (1991) In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 337:1610–1611CrossRefPubMed
15.
Zurück zum Zitat Graham GD, Petroff OAC, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW (1993) Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 43:2065–2068PubMed Graham GD, Petroff OAC, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW (1993) Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 43:2065–2068PubMed
16.
Zurück zum Zitat Shyu W-C, Lee C-C, Hsu Y-D et al (1996) Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance spectroscopy. J Neurol Sci 138:157–160CrossRefPubMed Shyu W-C, Lee C-C, Hsu Y-D et al (1996) Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance spectroscopy. J Neurol Sci 138:157–160CrossRefPubMed
17.
Zurück zum Zitat Konaka K, Kaido M, Okuda Y et al (2000) Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 42:662–665CrossRefPubMed Konaka K, Kaido M, Okuda Y et al (2000) Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 42:662–665CrossRefPubMed
18.
Zurück zum Zitat Galanaud D, Dormont D, Grabli D, Charles P, Hauw JJ, Lubetzki C, Brandel JP, Marsault C, Cozzone PJ (2002) MR spectroscopic pulvinar sign in a case of variant Creutzfeldt-Jakob disease. J Neuroradiol 29(4):285–287PubMed Galanaud D, Dormont D, Grabli D, Charles P, Hauw JJ, Lubetzki C, Brandel JP, Marsault C, Cozzone PJ (2002) MR spectroscopic pulvinar sign in a case of variant Creutzfeldt-Jakob disease. J Neuroradiol 29(4):285–287PubMed
19.
Zurück zum Zitat Pandya HG, Coley SC, Wilkinson ID and Griffiths PD (2003) Magnetic resonance spectroscopy abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 58:148–153CrossRefPubMed Pandya HG, Coley SC, Wilkinson ID and Griffiths PD (2003) Magnetic resonance spectroscopy abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 58:148–153CrossRefPubMed
20.
Zurück zum Zitat Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679PubMedCrossRef Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679PubMedCrossRef
21.
Zurück zum Zitat Valenzuela MJ, Sachdev P (2001). Magnetic resonance spectroscopy in AD. Neurology 56:592–598PubMed Valenzuela MJ, Sachdev P (2001). Magnetic resonance spectroscopy in AD. Neurology 56:592–598PubMed
22.
Zurück zum Zitat Behar KL, Boucher R, Fritch W, Manuelidis L (1998) Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. Magn Reson Imaging 16:963–968CrossRefPubMed Behar KL, Boucher R, Fritch W, Manuelidis L (1998) Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease. Magn Reson Imaging 16:963–968CrossRefPubMed
23.
Zurück zum Zitat Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG (2002) Quantification of neurons in Alzheimer and control brains with ex vivo high-resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 20(7):527–533CrossRefPubMed Cheng LL, Newell K, Mallory AE, Hyman BT, Gonzalez RG (2002) Quantification of neurons in Alzheimer and control brains with ex vivo high-resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magn Reson Imaging 20(7):527–533CrossRefPubMed
24.
Zurück zum Zitat Salibi N, Brown MA (1997) Clinical MR spectroscopy. First principles. Chapter 6; 143–202. Wiley-Liss, John Wiley & Sons, Inc. USA Salibi N, Brown MA (1997) Clinical MR spectroscopy. First principles. Chapter 6; 143–202. Wiley-Liss, John Wiley & Sons, Inc. USA
25.
Zurück zum Zitat Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15(3–5):289–298PubMedCrossRef Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15(3–5):289–298PubMedCrossRef
26.
Zurück zum Zitat Strange K, Emma F, Paredes A, Morrison R (1994) Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 12(1):35–43CrossRefPubMed Strange K, Emma F, Paredes A, Morrison R (1994) Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 12(1):35–43CrossRefPubMed
27.
Zurück zum Zitat Ironside JW, Bell JE (1997) Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet 350:1475CrossRefPubMed Ironside JW, Bell JE (1997) Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet 350:1475CrossRefPubMed
28.
Zurück zum Zitat Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (1996) High brain myo-inositol levels in the predementia phase of Alzheimer’s disease in adults with Down’s syndrome. Am J Psychiatry 156:1879–1886 Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (1996) High brain myo-inositol levels in the predementia phase of Alzheimer’s disease in adults with Down’s syndrome. Am J Psychiatry 156:1879–1886
29.
Zurück zum Zitat Kantarci K, Jack CR, Xu YC, Campeau NG, O’Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease. Neurology 55:210–217PubMed Kantarci K, Jack CR, Xu YC, Campeau NG, O’Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease. Neurology 55:210–217PubMed
Metadaten
Titel
Short TE Quantitative Proton Magnetic Resonance Spectroscopy in Variant Creutzfeldt-Jakob Disease
verfasst von
R. J. Cordery
D. MacManus
A. Godbolt
M. N. Rossor
A. D. Waldman
Publikationsdatum
01.08.2006
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 8/2006
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-0090-4

Weitere Artikel der Ausgabe 8/2006

European Radiology 8/2006 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.